• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A randomized comparison of triptorelin and tamoxifen as treatment of progressive ovarian cancer.

作者信息

Jager W, Sauerbrei W, Beck E, Maassen V, Stumpfe M, Meier W, Kuhn W, Janicke F

机构信息

Department of Obstetrics and Gynaecology, Friedrich Alexander University, Erlangen, Germany.

出版信息

Anticancer Res. 1995 Nov-Dec;15(6B):2639-42.

PMID:8669839
Abstract
摘要

相似文献

1
A randomized comparison of triptorelin and tamoxifen as treatment of progressive ovarian cancer.曲普瑞林与他莫昔芬治疗进展期卵巢癌的随机对照研究
Anticancer Res. 1995 Nov-Dec;15(6B):2639-42.
2
Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group.
Cancer. 1996 Oct 1;78(7):1452-60. doi: 10.1002/(SICI)1097-0142(19961001)78:7<1452::AID-CNCR12>3.0.CO;2-Z.
3
Editorial. Endometrioid epithelial ovarian cancer.
Cancer. 2008 May 15;112(10):2108-11. doi: 10.1002/cncr.23439.
4
Endocrine therapy in the management of low-grade serous ovarian/peritoneal carcinoma: Mounting evidence for therelative efficacy of tamoxifen and aromatase inhibitors.低度浆液性卵巢/腹膜癌治疗中的内分泌治疗：他莫昔芬和芳香化酶抑制剂相对疗效的证据不断增加。
Gynecol Oncol. 2020 Dec;159(3):601-603. doi: 10.1016/j.ygyno.2020.09.049. Epub 2020 Oct 2.
5
Progressive epithelial ovarian carcinoma. Prognostic factors and clinical management.进展期上皮性卵巢癌。预后因素与临床管理。
Dan Med Bull. 2006 Aug;53(3):232-57.
6
Ovarian ablation as adjuvant therapy for early-stage breast cancer.卵巢去势作为早期乳腺癌的辅助治疗
Cancer Treat Res. 1998;94:158-80.
7
[Current status of adjuvant endocrine therapy for hormone responsive breast cancer].[激素反应性乳腺癌辅助内分泌治疗的现状]
Gan To Kagaku Ryoho. 2001 Jul;28(7):902-8.
8
Whither tamoxifen.他莫昔芬何去何从。
Gynecol Oncol. 1996 Jul;62(1):1-3. doi: 10.1006/gyno.1996.0180.
9
Tamoxifen as treatment for gynecomastia and mastodynia resulting from hormonal deprivation.他莫昔芬用于治疗因激素剥夺引起的男性乳房发育症和乳腺疼痛。
J Urol. 1998 Apr;159(4):1309.
10
The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer.他莫昔芬在晚期上皮性卵巢癌患者中的疗效。
Med Oncol. 2007;24(1):39-43. doi: 10.1007/BF02685901.

引用本文的文献

1
Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications (Review).卵巢癌的激素治疗：强调机制与应用（综述）。
Oncol Rep. 2021 Oct;46(4). doi: 10.3892/or.2021.8174. Epub 2021 Aug 26.
2
Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.用于治疗复发性上皮性卵巢癌的促黄体生成素释放激素（LHRH）激动剂。
Cochrane Database Syst Rev. 2016 Jun 29;2016(6):CD011322. doi: 10.1002/14651858.CD011322.pub2.
3
New insights on the role of hormonal therapy in ovarian cancer.
激素疗法在卵巢癌中作用的新见解。
Steroids. 2013 Jun;78(6):530-7. doi: 10.1016/j.steroids.2013.01.008. Epub 2013 Feb 8.
4
Hormone response in ovarian cancer: time to reconsider as a clinical target?卵巢癌中的激素反应：是否应重新考虑将其作为临床靶点？
Endocr Relat Cancer. 2012 Nov 9;19(6):R255-79. doi: 10.1530/ERC-12-0175. Print 2012 Dec.
5
Revisiting the role of antiandrogen strategies in ovarian cancer.重新探讨抗雄激素策略在卵巢癌中的作用。
Oncologist. 2011;16(10):1413-21. doi: 10.1634/theoncologist.2011-0164. Epub 2011 Sep 23.
6
Antiestrogen therapy in recurrent ovarian cancer resulting in 28 months of stable disease: a case report and review of the literature.抗雌激素疗法治疗复发性卵巢癌获28个月疾病稳定：一例病例报告及文献综述
Arch Oncol. 2010;18(1-2):32-35. doi: 10.2298/AOO1002032K.
7
Tamoxifen for relapse of ovarian cancer.他莫昔芬用于卵巢癌复发的治疗。
Cochrane Database Syst Rev. 2010 Mar 17;2010(3):CD001034. doi: 10.1002/14651858.CD001034.pub2.
8
The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer.他莫昔芬在晚期上皮性卵巢癌患者中的疗效。
Med Oncol. 2007;24(1):39-43. doi: 10.1007/BF02685901.
9
Estrogen receptors and human disease.雌激素受体与人类疾病。
J Clin Invest. 2006 Mar;116(3):561-70. doi: 10.1172/JCI27987.
10
Estrogen, progesterone and epithelial ovarian cancer.雌激素、孕激素与上皮性卵巢癌
Reprod Biol Endocrinol. 2003 Oct 7;1:73. doi: 10.1186/1477-7827-1-73.